Ann: Execution of US Provider Agreements, page-24

Would have preferred a firm purchase order, but increasing its presence in the US always a good thing. Expecting another purchase order ahead of NASDAQ listing and hopefully regulatory approval.

Clearly some investors jumping off which is fine given the last 4C - personally I'm not going to die wondering so will hold.

this is a high risk investment with a solid platform for growth. it has missed key regulatory approvals etc but the fact they are getting some contracts is encouraging.

Not sure we should be in full panic stations, but every investor has their own risk tolerance and will need to exit if required. Liquidity is not helping.

As mentioned, some crucial few months are coming up but the company has market access and a growing customer base in the US. Waiting on CFDA to open up China and confirmation of another purchase order in the next couple months.

happy to hold, may accrue some more here of the next few weeks